Novartis AG has agreed to buy Nestle AG’s 77 percent stake in U.S. company Alcon in a deal worth up to $39 billion to boost its eye care business, the Swiss drugmaker said on Monday.
*For more on this story,
read the full Reuters article.
Novartis AG has agreed to buy Nestle AG’s 77 percent stake in U.S. company Alcon in a deal worth up to $39 billion to boost its eye care business, the Swiss drugmaker said on Monday.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99